BCRX Insider Trading

Insider Ownership Percentage: 4.40%
Insider Buying (Last 12 Months): $498,441.60
Insider Selling (Last 12 Months): $31,920.00

BioCryst Pharmaceuticals Insider Trading History Chart

This chart shows the insider buying and selling history at BioCryst Pharmaceuticals by year and by quarter.

Skip ChartChart Data in Insider Trading History Table

BioCryst Pharmaceuticals Share Price & Price History

Current Price: $6.28
Price Change: Price Decrease of -0.19 (-2.94%)
As of 05/17/2024 09:53 PM ET

This chart shows the closing price history over time for BCRX up to the past year.

Skip Chart and Table DataPrice Data in Insider Trading History Table
Days: 30 | 90 | 365

BioCryst Pharmaceuticals Insider Trading History

Transaction DateInsider NameTitleBuy/SellNumber of SharesAverage Share PriceTotal TransactionShares Held After TransactionDetails
5/14/2024Anthony DoyleCFOBuy36,300$5.57$202,191.00266,744View SEC Filing Icon  
5/14/2024Helen M ThackrayInsiderBuy30,000$5.86$175,800.00272,139View SEC Filing Icon  
5/13/2024Steven K GalsonDirectorBuy21,940$5.49$120,450.6051,551View SEC Filing Icon  
6/15/2023Machelle SandersDirectorSell4,000$7.98$31,920.0025,611View SEC Filing Icon  
2/1/2023Jon P. StonehouseCEOSell100,000$10.38$1,038,000.001,008,739View SEC Filing Icon  
12/15/2022Anthony DoyleCFOSell5,700$10.90$62,130.00163,966View SEC Filing Icon  
12/15/2022Helen M ThackrayInsiderSell3,125$10.89$34,031.25133,275View SEC Filing Icon  
12/15/2022Jon P. StonehouseCEOSell14,100$10.90$153,690.00887,730View SEC Filing Icon  
12/15/2022Michael L JonesDirectorSell445$10.90$4,850.5010,753View SEC Filing Icon  
12/2/2022Jon P. StonehouseCEOSell82,656$12.80$1,057,996.80901,830View SEC Filing Icon  
12/1/2022Michael L JonesDirectorSell8,600$13.01$111,886.0011,198View SEC Filing Icon  
11/14/2022Yarlagadda S. BabuInsiderSell31,515$13.88$437,428.20298,541View SEC Filing Icon  
4/1/2022Helen M ThackrayInsiderSell7,600$16.20$123,120.00136,400View SEC Filing Icon  
2/15/2022George B. AbercrombieDirectorSell5,000$18.50$92,500.00View SEC Filing Icon  
1/11/2022Jon P. StonehouseCEOSell184,000$15.04$2,767,360.00View SEC Filing Icon  
12/7/2021Yarlagadda S. BabuInsiderSell30,100$12.20$367,220.00View SEC Filing Icon  
11/24/2021Vincent MilanoDirectorBuy7,500$12.19$91,425.00View SEC Filing Icon  
11/23/2021Anthony DoyleCFOBuy35,258$12.48$440,019.84View SEC Filing Icon  
11/15/2021George B. AbercrombieDirectorSell5,000$12.27$61,350.00View SEC Filing Icon  
10/15/2021Nancy J. HutsonDirectorSell105,000$15.40$1,617,000.00View SEC Filing Icon  
9/10/2021George B. AbercrombieDirectorSell74,000$15.09$1,116,660.00View SEC Filing Icon  
7/15/2021George B. AbercrombieDirectorSell5,000$15.69$78,450.008,000View SEC Filing Icon  
5/27/2021William P. SheridanInsiderSell71,759$15.00$1,076,385.0039,434View SEC Filing Icon  
5/24/2021George B. AbercrombieDirectorSell6,667$13.90$92,671.309,667View SEC Filing Icon  
See Full Table

SEC Filings (Institutional Ownership Changes) for BioCryst Pharmaceuticals (NASDAQ:BCRX)

85.88% of BioCryst Pharmaceuticals stock is owned by institutions. Institutional ownership can be a sign of analyst confidence in the fundamentals of the stock.

Institutional Buying and Selling by Quarter

This chart shows the instiutional buying and selling at BCRX by year and by quarter.

Skip Institutional Buying and Selling Chart and Table DataRead Chart Data in Institutional Trading History Table

BioCryst Pharmaceuticals Institutional Trading History

Reporting DateHedge FundShares HeldMarket Value% of PortfolioQuarterly Change in SharesOwnership in CompanyDetails
5/17/2024Tidal Investments LLC55,560$0.28M0.0%N/A0.027%Search for SEC Filing on Google Icon
5/16/2024Redwood Investment Management LLC122,270$0.62M0.1%N/A0.059%Search for SEC Filing on Google Icon
5/16/2024California State Teachers Retirement System184,788$0.94M0.0%-7.6%0.090%Search for SEC Filing on Google Icon
5/16/2024Jacobs Levy Equity Management Inc.156,119$0.79M0.0%+62.0%0.076%Search for SEC Filing on Google Icon
5/16/2024Kynam Capital Management LP6,527,491$33.16M3.5%+41.9%3.163%Search for SEC Filing on Google Icon
5/15/2024Sarissa Capital Management LP1,094,168$5.56M1.0%+9.4%0.530%Search for SEC Filing on Google Icon
5/15/2024Price T Rowe Associates Inc. MD130,775$0.67M0.0%+15.0%0.063%Search for SEC Filing on Google Icon
5/14/2024Nan Fung Group Holdings Ltd36,847$0.19M0.2%+106.5%0.018%Search for SEC Filing on Google Icon
5/14/2024EntryPoint Capital LLC42,679$0.22M0.2%+689.8%0.021%Search for SEC Filing on Google Icon
5/14/2024Shell Asset Management Co.21,854$0.11M0.0%N/A0.011%Search for SEC Filing on Google Icon
5/14/2024Natixis11,684$59K0.0%+400.6%0.006%Search for SEC Filing on Google Icon
5/13/2024Seven Eight Capital LP11,254$57K0.0%N/A0.005%Search for SEC Filing on Google Icon
5/10/2024Vanguard Group Inc.17,676,767$89.80M0.0%-0.5%8.567%Search for SEC Filing on Google Icon
5/8/2024ProShare Advisors LLC48,503$0.25M0.0%+9.1%0.024%Search for SEC Filing on Google Icon
5/8/2024Russell Investments Group Ltd.58,725$0.30M0.0%+200.8%0.028%Search for SEC Filing on Google Icon
5/8/2024Inspire Investing LLC69,466$0.35M0.0%+9.7%0.034%Search for SEC Filing on Google Icon
5/7/2024Susquehanna Fundamental Investments LLC64,365$0.33M0.0%N/A0.031%Search for SEC Filing on Google Icon
5/7/2024Swiss National Bank363,968$1.85M0.0%-2.5%0.176%Search for SEC Filing on Google Icon
5/7/2024SG Americas Securities LLC13,548$69K0.0%-79.5%0.007%Search for SEC Filing on Google Icon
5/2/2024Mutual of America Capital Management LLC212,781$1.08M0.0%-4.0%0.103%Search for SEC Filing on Google Icon
5/1/2024BNP Paribas Financial Markets167,782$0.85M0.0%-78.8%0.081%Search for SEC Filing on Google Icon
5/1/2024Mirae Asset Global Investments Co. Ltd.138,074$0.70M0.0%+13.0%0.067%Search for SEC Filing on Google Icon
4/30/2024J.W. Cole Advisors Inc.12,600$64K0.0%-37.3%0.006%Search for SEC Filing on Google Icon
4/29/2024China Universal Asset Management Co. Ltd.39,639$0.20M0.0%+67.3%0.019%Search for SEC Filing on Google Icon
4/24/2024Assenagon Asset Management S.A.386,885$1.97M0.0%-26.9%0.188%Search for SEC Filing on Google Icon
4/23/2024Rice Hall James & Associates LLC2,151,545$10.93M0.6%-2.1%1.044%Search for SEC Filing on Google Icon
4/5/2024Los Angeles Capital Management LLC89,614$0.46M0.0%+68.0%0.043%Search for SEC Filing on Google Icon
3/11/2024Vanguard Group Inc.17,763,720$106.41M0.0%+15.4%8.617%Search for SEC Filing on Google Icon
3/5/2024Fisher Asset Management LLC2,884,569$17.28M0.0%-9.4%1.399%Search for SEC Filing on Google Icon
2/27/2024Counterweight Ventures LLC13,500$81K0.1%N/A0.007%Search for SEC Filing on Google Icon
2/20/2024Quarry LP9,000$54K0.0%N/A0.004%Search for SEC Filing on Google Icon
2/14/2024Oracle Investment Management Inc.535,558$3.21M2.0%-3.6%0.261%Search for SEC Filing on Google Icon
2/14/2024Braidwell LP5,718,477$34.25M1.3%+6.6%2.792%Search for SEC Filing on Google Icon
2/14/2024Avoro Capital Advisors LLC13,050,000$78.17M1.1%+13.0%6.372%Search for SEC Filing on Google Icon
2/14/2024Kynam Capital Management LP4,600,000$27.55M3.1%+46.8%2.246%Search for SEC Filing on Google Icon
2/13/2024Tower Research Capital LLC TRC10,420$62K0.0%+131.1%0.005%Search for SEC Filing on Google Icon
2/13/2024Rafferty Asset Management LLC955,587$5.72M0.0%+18.3%0.467%Search for SEC Filing on Google Icon
2/12/2024Capstone Investment Advisors LLC18,650$0.11M0.0%N/A0.009%Search for SEC Filing on Google Icon
2/9/2024Aigen Investment Management LP12,670$76K0.0%-91.7%0.006%Search for SEC Filing on Google Icon
2/9/2024GW&K Investment Management LLC2,337,683$14M0.1%-9.1%1.141%Search for SEC Filing on Google Icon
2/9/2024Trexquant Investment LP421,516$2.53M0.1%-28.9%0.206%Search for SEC Filing on Google Icon
2/9/2024Norges Bank2,216,612$13.28M0.0%N/A1.082%Search for SEC Filing on Google Icon
2/8/2024Panagora Asset Management Inc.669,067$4.01M0.0%-8.0%0.327%Search for SEC Filing on Google Icon
2/8/2024Pinnacle Wealth Planning Services Inc.20,561$0.12M0.0%N/A0.010%Search for SEC Filing on Google Icon
2/7/2024Jump Financial LLC128,771$0.77M0.0%-68.2%0.063%Search for SEC Filing on Google Icon
2/7/2024BNP Paribas Financial Markets790,163$4.73M0.0%+45.5%0.386%Search for SEC Filing on Google Icon
2/7/2024Teacher Retirement System of Texas43,827$0.26M0.0%-18.3%0.021%Search for SEC Filing on Google Icon
2/7/2024E Fund Management Co. Ltd.51,317$0.31M0.0%+23.7%0.025%Search for SEC Filing on Google Icon
2/6/2024Charles Schwab Investment Management Inc.1,594,436$9.55M0.0%+9.1%0.778%Search for SEC Filing on Google Icon
2/6/2024Amalgamated Bank24,257$0.15M0.0%-7.2%0.012%Search for SEC Filing on Google Icon
2/6/2024Los Angeles Capital Management LLC53,330$0.32M0.0%+61.0%0.026%Search for SEC Filing on Google Icon
2/6/2024Swiss National Bank373,468$2.24M0.0%-10.1%0.182%Search for SEC Filing on Google Icon
2/6/2024Fisher Asset Management LLC2,884,097$17.28M0.0%-9.5%1.408%Search for SEC Filing on Google Icon
2/5/2024Victory Capital Management Inc.26,842$0.16M0.0%+31.5%0.013%Search for SEC Filing on Google Icon
2/1/2024New York State Common Retirement Fund59,075$0.35M0.0%-23.2%0.029%Search for SEC Filing on Google Icon
2/1/2024Handelsbanken Fonder AB45,900$0.28M0.0%+29.3%0.022%Search for SEC Filing on Google Icon
1/31/2024abrdn plc504,528$3.02M0.0%N/A0.246%Search for SEC Filing on Google Icon
1/30/2024Zurcher Kantonalbank Zurich Cantonalbank47,359$0.28M0.0%+27.1%0.023%Search for SEC Filing on Google Icon
1/30/2024Mackenzie Financial Corp23,439$0.14M0.0%+74.7%0.011%Search for SEC Filing on Google Icon
1/26/2024Mutual of America Capital Management LLC221,552$1.33M0.0%-1.7%0.108%Search for SEC Filing on Google Icon
1/25/2024MA Private Wealth12,700$76K0.0%N/A0.006%Search for SEC Filing on Google Icon
1/24/2024Mirae Asset Global Investments Co. Ltd.122,180$0.73M0.0%+6.3%0.060%Search for SEC Filing on Google Icon
1/24/2024China Universal Asset Management Co. Ltd.23,692$0.14M0.0%+387.0%0.012%Search for SEC Filing on Google Icon
1/19/2024JGP Global Gestao de Recursos Ltda.10,650$64K0.1%N/A0.005%Search for SEC Filing on Google Icon
1/17/2024Assenagon Asset Management S.A.529,419$3.17M0.0%-52.3%0.258%Search for SEC Filing on Google Icon
1/12/2024SG Americas Securities LLC66,223$0.40M0.0%N/A0.032%Search for SEC Filing on Google Icon
12/18/2023Vanguard Group Inc.15,392,319$108.98M0.0%+2.0%7.515%Search for SEC Filing on Google Icon
11/17/2023Jacobs Levy Equity Management Inc.470,137$3.33M0.0%-59.3%0.230%Search for SEC Filing on Google Icon
11/15/2023GSA Capital Partners LLP191,527$1.36M0.1%+167.8%0.094%Search for SEC Filing on Google Icon
11/15/2023Rock Springs Capital Management LP2,551,226$18.06M0.5%+2.2%1.246%Search for SEC Filing on Google Icon
11/15/2023Kynam Capital Management LP3,133,193$22.18M3.6%+10.0%1.530%Search for SEC Filing on Google Icon
11/15/2023ELCO Management Co. LLC31,811$0.23M0.2%+134.9%0.016%Search for SEC Filing on Google Icon
11/15/2023AXQ Capital LP23,134$0.16M0.1%+31.9%0.011%Search for SEC Filing on Google Icon
11/14/2023Braidwell LP5,362,980$37.97M1.2%+92.1%2.619%Search for SEC Filing on Google Icon
11/14/2023Gotham Asset Management LLC69,033$0.49M0.0%N/A0.034%Search for SEC Filing on Google Icon
11/14/2023Deerfield Management Company L.P. Series C3,286,000$23.27M0.5%+148.6%1.604%Search for SEC Filing on Google Icon
11/14/2023Teza Capital Management LLC36,904$0.26M0.0%+12.8%0.018%Search for SEC Filing on Google Icon
11/14/2023Trexquant Investment LP592,612$4.20M0.1%+76.6%0.289%Search for SEC Filing on Google Icon
11/14/2023Profund Advisors LLC136,652$0.97M0.1%-22.7%0.067%Search for SEC Filing on Google Icon
11/13/2023Connor Clark & Lunn Investment Management Ltd.542,776$3.84M0.0%+35.3%0.265%Search for SEC Filing on Google Icon
11/13/2023Algert Global LLC207,095$1.47M0.1%-29.0%0.101%Search for SEC Filing on Google Icon
11/13/2023Healthcare of Ontario Pension Plan Trust Fund384,000$2.72M0.0%N/A0.187%Search for SEC Filing on Google Icon
11/13/2023Visionary Wealth Advisors33,540$0.24M0.0%-13.0%0.016%Search for SEC Filing on Google Icon
11/13/2023Silverarc Capital Management LLC791,671$5.61M1.7%+4.0%0.387%Search for SEC Filing on Google Icon
11/13/2023Aigen Investment Management LP153,474$1.09M0.2%+96.0%0.075%Search for SEC Filing on Google Icon
11/13/2023FMR LLC2,953,373$20.91M0.0%+0.1%1.442%Search for SEC Filing on Google Icon
11/13/2023Rafferty Asset Management LLC807,888$5.72M0.0%-17.1%0.394%Search for SEC Filing on Google Icon
11/13/2023Kestra Advisory Services LLC18,779$0.13M0.0%-28.0%0.009%Search for SEC Filing on Google Icon
11/13/2023PNC Financial Services Group Inc.11,917$84K0.0%-33.6%0.006%Search for SEC Filing on Google Icon
11/13/2023E Fund Management Co. Ltd.41,497$0.29M0.0%-20.8%0.020%Search for SEC Filing on Google Icon
11/9/2023Rhumbline Advisers295,335$2.09M0.0%-5.9%0.156%Search for SEC Filing on Google Icon
11/9/2023Deutsche Bank AG99,711$0.71M0.0%+11.8%0.053%Search for SEC Filing on Google Icon
11/9/2023Mutual of America Capital Management LLC225,323$1.60M0.0%+2.5%0.119%Search for SEC Filing on Google Icon
11/9/2023UBS Group AG305,951$2.17M0.0%-21.2%0.161%Search for SEC Filing on Google Icon
11/8/2023Charles Schwab Investment Management Inc.1,460,807$10.34M0.0%+1.3%0.771%Search for SEC Filing on Google Icon
11/8/2023Swiss National Bank415,368$2.94M0.0%+1.2%0.219%Search for SEC Filing on Google Icon
11/7/2023Virtus ETF Advisers LLC38,321$0.27M0.2%-11.5%0.020%Search for SEC Filing on Google Icon
11/7/2023Quantbot Technologies LP64,100$0.45M0.0%N/A0.034%Search for SEC Filing on Google Icon
11/7/2023New York State Common Retirement Fund76,896$0.54M0.0%+23.2%0.041%Search for SEC Filing on Google Icon
11/7/2023Barclays PLC547,328$3.88M0.0%-0.4%0.289%Search for SEC Filing on Google Icon
Data available starting January 2016

See Full Table
BioCryst Pharmaceuticals logo
BioCryst Pharmaceuticals, Inc., a biotechnology company, develops oral small-molecule and protein therapeutics to treat rare diseases. The company markets peramivir injection, an intravenous neuraminidase inhibitor for the treatment of acute uncomplicated influenza under the RAPIVAB, RAPIACTA, and PERAMIFLU names; and ORLADEYO, an oral serine protease inhibitor to treat hereditary angioedema. It is also developing BCX10013, an oral factor D inhibitor for complement-mediated diseases. The company has collaborations and in-license relationships with the Torii Pharmaceutical Co., Ltd.; Seqirus UK Limited; Shionogi & Co., Ltd.; Green Cross Corporation; National Institute of Allergy and Infectious Diseases; Biomedical Advanced Research and Development Authority; the U.S. Department of Health and Human Services; and The University of Alabama at Birmingham, as well as Albert Einstein College of Medicine of Yeshiva University and Industrial Research, Ltd. BioCryst Pharmaceuticals, Inc. was founded in 1986 and is headquartered in Durham, North Carolina.
Read More on BioCryst Pharmaceuticals

Today's Range

Now: $6.28
Low: $6.22
High: $6.56

50 Day Range

MA: $4.95
Low: $4.13
High: $6.47

52 Week Range

Now: $6.28
Low: $4.03
High: $8.96

Volume

4,378,800 shs

Average Volume

3,494,553 shs

Market Capitalization

$1.30 billion

P/E Ratio

N/A

Dividend Yield

N/A

Beta

1.96

Who are the company insiders with the largest holdings of BioCryst Pharmaceuticals?

BioCryst Pharmaceuticals' top insider shareholders include:
  1. Jon P Stonehouse (CEO)
  2. Yarlagadda S Babu (Insider)
  3. Helen M Thackray (Insider)
  4. Anthony Doyle (CFO)
  5. Steven K Galson (Director)
  6. Machelle Sanders (Director)
  7. Michael L Jones (Director)
Learn More about top insider investors at BioCryst Pharmaceuticals.

Who are the major institutional investors of BioCryst Pharmaceuticals?

BioCryst Pharmaceuticals' top institutional shareholders include:
  1. Vanguard Group Inc. — 8.57%
  2. Kynam Capital Management LP — 3.16%
  3. Rice Hall James & Associates LLC — 1.04%
  4. Sarissa Capital Management LP — 0.53%
  5. Assenagon Asset Management S.A. — 0.19%
  6. Swiss National Bank — 0.18%
Learn More about top institutional investors of BioCryst Pharmaceuticals stock.

Which major investors are selling BioCryst Pharmaceuticals stock?

During the last quarter, BCRX stock was sold by these institutional investors:
  1. BNP Paribas Financial Markets
  2. Assenagon Asset Management S.A.
  3. Vanguard Group Inc.
  4. SG Americas Securities LLC
  5. Rice Hall James & Associates LLC
  6. California State Teachers Retirement System
  7. Swiss National Bank
  8. Mutual of America Capital Management LLC

Which major investors are buying BioCryst Pharmaceuticals stock?

In the last quarter, BCRX stock was acquired by institutional investors including:
  1. Kynam Capital Management LP
  2. Redwood Investment Management LLC
  3. Sarissa Capital Management LP
  4. Susquehanna Fundamental Investments LLC
  5. Jacobs Levy Equity Management Inc.
  6. Tidal Investments LLC
  7. Simplex Trading LLC
  8. Russell Investments Group Ltd.
Within the previous year, these company insiders have bought BioCryst Pharmaceuticals stock:
  1. Jon P Stonehouse (CEO)
  2. Yarlagadda S Babu (Insider)
  3. Helen M Thackray (Insider)
Learn More investors buying BioCryst Pharmaceuticals stock.